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Summary
In this study, we describe the distribution of various
classes of proteoglycans and their potential matrix
ligand, hyaluronan, during neural crest development in
the trunk region of the chicken embryo. Different types
of chondroitin and keratan sulfate proteoglycans were
recognized using a panel of monoclonal antibodies
produced against specific epitopes on their glycosamino-
glycan chains. A heparan sulfate proteoglycan was
identified by an antibody against its core protein. The
distribution of hyaluronan was mapped using a biotinyl-
ated fragment that corresponds to the hyaluronan-
binding region of cartilage proteoglycans. Four major
patterns of proteoglycan immunoreactivity were ob-
served. (1) Chondroitin-6-sulfate-rich proteoglycans and
certain keratan sulfate proteoglycans were absent from
regions containing migrating neural crest cells, but were
present in interstitial matrices and basement membranes
along prospective migratory pathways such as the
ventral portion of the sclerotome. Although initially
distributed uniformly along the rostrocaudal extent of
the sclerotome, these proteoglycans became rearranged
to the caudal portion of the sclerotome with progressive
migration of neural crest cells through the rostral
sclerotome and their aggregation into peripheral
ganglia. (2) A subset of chondroitin/keratan sulfate
proteoglycans bearing primarily unsulfated chondroitin
chains was observed exclusively in regions where neural
crest cells were absent or delayed from entering, such as
the perinotochordal and subepidermal spaces. (3) A
subset of chondroitin/keratan sulfate proteoglycans was
restricted to the perinotochordal region and, following
gangliogenesis, was arranged in a metameric pattern
corresponding to the sites where presumptive vertebral
arches form. (4) Certain keratan sulfate proteoglycans
and a heparan sulfate proteoglycan were observed in
basement membranes and in an interstitial matrix
uniformly distributed along the rostrocaudal extent of
the sclerotome. After gangliogenesis, the neural crest-
derived dorsal root and sympathetic ganglia contained
both these proteoglycan types, but were essentially free
of other chondroitin/keratan-proteoglycan subsets.
Hyaluronan generally colocalized with the first set of
proteoglycans, but also was concentrated around mi-
grating neural crest cells and was reduced in neural
crest-derived ganglia. These observations demonstrate
that proteoglycans have diverse and dynamic distri-
butions during times of neural crest development and
chondrogenesis of the presumptive vertebrae. In gen-
eral, chondroitin/keratan sulfate proteoglycans are
abundant in regions where neural crest cells are absent,
and their segmental distribution inversely correlates
with that of neural crest-derived ganglia.
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Introduction
Neural crest cells migrate long distances along pathways
containing an intricate extracellular matrix (ECM). As
a consequence, the ECM is thought to play a central
role in several aspects of neural crest development. In
vitro, neural crest cells migrate avidly on numerous
ECM molecules including fibronectin, laminin and
collagens (Newgreen and Erickson, 1986; Perris and
Johansson, 1987; Perris etal. 1989; Perris et al. 1990a),
suggesting that individual matrix components may serve
as permissive migratory substrates. Ultrastructural
studies performed in situ reveal that neural crest cells
form specialized contacts with this fibrillar matrix
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network encountered during migration (Lofberg et al.
1980; Newgreen and Erickson, 1986; Penis et al.
1990b). In ovo injections of antibodies against indi-
vidual matrix molecules or their cell surface receptors
results in abnormal neural crest development in vivo
(Bronner-Fraser, 1985, 1986a; Bronner-Fraser and
Lallier, 1988; Bronner-Fraser, 1988). Moreover, trans-
plantations of regionally and temporally denned
matrices adsorbed onto membrane microcarriers have
provided evidence that the ECM can prematurely
promote the onset of neural crest cell movement in vivo
(Lofberg et al. 1985, 1988).
A logical first step in establishing the role of the ECM
in neural crest cell migration is to determine its
structural and molecular composition at various phases
of neural crest development. Ultrastructural and
immunohistochemical studies have revealed that the
interstitial matrix along trunk neural crest migratory
pathways consists of a fibrillar collagenous network,
which contains abundant amounts of fibronectin,
tenascin/cytotactin and glycosaminoglycans (Newgreen
and Erickson, 1986; Perris and Bronner-Fraser, 1989;
Perris et al. 1990a; Newgreen et al. 1986, 1990).
Basement membrane matrices, enriched in laminin and
collagen type IV, also line some neural crest migratory
routes (Newgreen and Erickson, 1986; Perris and
Bronner-Fraser, 1989; Perris et al. 19906).
Although a great deal of information has been
compiled regarding the distribution and possible func-
tion of cell adhesion glycoproteins such as fibronectin,
laminin, cytotactin/tenascin and various collagens
during neural crest cell migration, far less is known
about the role of proteoglycans in this process.
Proteoglycans represent a heterogeneous population of
molecules that contribute to the compositional diversity
of the ECM. Indirect evidence that proteoglycans might
be well-represented during neural crest development
has emerged from a series of histochemical studies
using cationic dyes, in situ metabolic labelling and
differential enzymatic degradation (Kvist and Finne-
gan, 1970; Pintar, 1978; Lofberg et al. 1980; Newgreen
et al. 1982, 1986; Perris et al. \99Qb). From these
observations it was concluded that several distinct
families of matrix and cell-associated proteoglycans
were expressed at various phases of neural crest
development. However, the nature and spatiotemporal
distribution of specific populations of proteoglycans
present at these early stages of development, as well as
their relationship to their potential ligands, such as
collagens and hyaluronan, has not been determined.
In this study, we have examined the distribution of
various proteoglycan subclasses in situ and have
determined their spatial and temporal organization
relative to the development of the trunk neural crest in
the chick embryo. For this purpose, a panel of
monoclonal antibodies that specifically detect native
carbohydrate structures of chick proteoglycans were
used in combination with differential enzymatic degra-
dation and antibodies generated against chondroiti-
nase-digested murine proteoglycans. In addition, a
specific probe for hyaluronan (Knudsen and Toole,
1985; Ripellino et al. 1985) was used to map the
distribution of this potential matrix and cell surface-
associated ligand for proteoglycans. Our observations
indicate that a time-related and region-specific organiz-
ation of diverse types of proteoglycans occurs during
neural crest cell migration and gangliogenesis, and the
onset of vertebral chondrogenesis.
Materials and methods
Production and screening of monoclonal antibodies
(mAbs) against chondroitin (CS) and keratan sulfate
(KS) chains of proteoglycans (PGs)
Native CS/KS-PG monomers were extracted from bone
marrow of femurs and tibias of 17 day old chick embryos using
4 M guanidine-HCl in the presence of protease inhibitors as
previously described (Oegema et al. 1975; Sorrell et al. 1988).
Solid CsCl was added to the extract to give the final density of
1.5gml"1, and the solution was centrifuged at 100000 g for
48 h. The bottom one third of the gradient, with the density of
1.6gml"', was collected, dialyzed against 0 .15 M NaCl, then
water and lyophilized as previously described (Sorrell et al.
1988). The purified, high buoyant density PGs (Dl fraction),
which have been shown to be substituted with both CS and KS
chains, were then used to immunize mice. The immunization
protocol and the protocol for the production of hybridoma
were as previously published (Caterson et al. 1987; Sorrell et
al. 1990). Clones resulting from the fusion were tested in
ELISA for the presence of antibodies that recognized the
marrow PGs as well as PGs from other sources. Antibodies
produced by nine such clones, 7D4, 6C3, 4C3, 4D3, 3D2,
1B4, 4D1, 2D3 and 8C2, were identified and classified as IgM
kappa. Each clone was then subcloned and used to produce
ascites fluid. The ascites fluid was further screened for the
ability of the antibody to identify epitopes on a number of
different purified CS/KS-PG monomers, in their intact form
or after alternative digestion with chondroitinase ABC and
keratanase (see below).
Other antibodies
MAbs 2B6, 1B5, 3B3 and 5D4 were obtained from Dr Bruce
Caterson, Division of Orthopaedics, Department of Surgery,
University of North Carolina, Chapel Hill, NC. The mAb
33-2, kindly provided by Dr Douglas Fambrough (The John
Hopkins University, Baltimore, MA), reacts with a core
protein-associated epitope located on a large molecular mass
HS-PG (MW>300xlOjMr) of embryonic chick skeletal
muscle (Bayne et al. 1984). The HNK-1 antibody was purified
from ascites fluid (American Tissue Culture, Inc) by column
chromatography on protamine sulfate followed by ammonium
sulfate precipitation. In some cases, the purified HNK-1
antibody was biotinylated using biotin-A'-hydroxysuccinamide
ester (Calbiochem) according to a previously published
procedure (Perris and Johansson, 1987; Perris et al. 1989).
ELISA
Proteoglycan monomers from shark cranial cartilage (Al),
embryonic chick epiphysial cartilage (Dl), bovine articular
cartilage (A1D1) bovine nasal cartilage (A1D1) and Swarm
rat chondrosarcoma (A1D1) were purified according to
previously published procedures (Oegema et al. 1975; Sorrell
et al. 1988, 1990). Wells of microtiter plates (Costar half area
plates) were coated with PG monomers 25-50 ^ g ml"1 (dry
weight) in PBS overnight at 4°C. Proteoglycan-free areas of
the wells were then blocked with 1 % BSA (v/w) in PBS for
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1-2 h at 37°C. In some experiments, wells with immobilized
PGs were digested for 5min at room temperature with
lO^i.u. mP'-lOOmi.u. ml"1 chondroitinase ABC (Sigma), or
70mi.u.ml~' Pseudomonas endo-/5-galactosidase (keratan-
ase; ICN Biochemicals Inc.), dissolved in Tris-HCl buffer,
pH7.6, containing protease inhibitors and 1% BSA.
Digested and untreated proteoglycan-coated wells were
extensively rinsed with cold PBS and incubated with the
various mAbs (1:100-1:700000) diluted in PBS for lh at
37 °C, followed by sequential incubation with horseradish
peroxidase-conjugated goat anti-mouse Ig (Southern Biotech-
nology) diluted 1:500 in 0.1 M Tris-0.9 % NaCl pH7.6 for 1 h
at 37°C, and o-phenylenediamine (0.4mgml~')/H2O2
(0.0015%). The enzyme reaction was stopped by addition of
2 M H2SO4 and the adsorbance readings were performed at
492 ran in a Bio-Rad microplate reader. Competitive ELISA
was carried out by coating microwell plates with 50/igml"1
monomers of shark cranial cartilage proteoglycan as indicated
above. Serial 50% dilutions of shark cranial cartilage, chick
bone marrow, chick epiphysial cartilage, bovine articular
cartilage or bovine nasal cartilage were prepared in PBS with
1 % BSA. Equal aliquots of diluted antigen, or buffer alone,
were added to a constant volume of antibody (6C3 diluted
1:25000; 7D4 diluted 1:150000; 4C3 diluted 1:6000) in the
same buffer, incubated at 37°C for 1 h, and then added to the
coated wells. Standard ELISA was performed as above. The
% inhibition was determined for three assays, averaged and
plotted versus /igml"' of competing antigen. The amount of
competing antigen required to give 50 % inhibition was then
obtained by extrapolation from the inhibition curves.
Preparation of the hyaluronan probe
A 65xlO3/Wr proteolytic fragment corresponding to the
hyaluronan-binding region of the bovine nasal cartilage
proteoglycan was generously provided by Dr Torward
Laurent (Department of Medical and Physiological Chemis-
try, Biomedical Center, Uppsala, Sweden). The fragment was
generated by affinity chromatography as previously described
(Tengblad, 1979; Laurent and Tengblad, 1980). The PG
fragment, with attached low molecular weight hyaluronan
(16—30 oligosaccharides) to preserve the hyaluronan-binding
activity, was biotinylated according to the same procedure as
indicated for the HNK-1 antibody. Purified hyaluronan
(human umbilical cord; MT 1000000; Sigma) was bound to
AH-Sepharose 4B (Pharmacia) as described by Tengblad
(1979). Before use, the biotinylated hyaluronan-binding
fragment was then dissociated from the hyaluronan oligosac-
charides by transfer to a 4M guanidine-HCl-50mM sodium
acetate buffer, pH5.8, containing 10 mM EDTA, 100 mM
6-aminohexanoic acid, 5mM benzamidine hydrochloride, and
2mM phenylmethylsulfonyl fluoride (PSMF; Sigma).
Preparation of tissues for immunohistochemistry
Chick embryos at developmental stages 14-23 were rapidly
frozen in liquid nitrogen-cooled isopentane and immediately
transferred to methanol precooled to — 80°C and stored at this
temperature for 3 days. They were then successively
transferred to -35°C for 1 day, -20°C for 2 days and 4°C for
2 days. Following cryofixation, embryos were embedded in
paraplast after one change of methanol:histosol (7:3), one
change of methanol:histosol (3:7), two changes of histosol,
one change of histosol:paraplast (1:1), and three changes of
paraplast at 20min for each step. A number of other
procedures, including direct fixation in modified Karnovsky's
fixative, 4% paraformaldehyde, Sainte-Marie, periodate-
lysine-paraformaldehyde and Zenker's fixatives followed by
paraplast embedding or cryosectioning were also tested and
were found to be significantly less efficient in retaining
reactivity for the various anti-proteoglycan mAbs. One
exception was the mAb 33-2 (anti-HS-PG antibody) for
which optimal preservation of immunoreactivity was obtained
after methanol fixation and cryosectioning. The latter was
accomplished according to previously published procedures
(Krotoski et al. 1986). Serial transverse, horizontal and
parasagittal sections through the mid-trunk level of the
embryo were cut at 10-20 um and mounted on gelatinized or
albuminized slides.
Enzymatic pre-digestions of tissue sections
In cases where antibody application was preceded by
enzymatic digestion, sections were incubated with the various
enzymes for 1-3h at 37°C. Streptomyces hyaluronidase
(Sigma) was used at 115i.u.ml~' in 0.1M sodium acetate
buffer, pH5.2, containing 250^gml~1 ovomucoid (trypsin
inhibitor O-IV), 1 mM PMSF, 1 mM EDTA, 1 mM iodoacetida-
mine and 200Ki.u. ml"1 aprotonin (all Sigma). Chondroiti-
nases ABC and AC II (Sigma) were used at 0.2i.u. ml"1 in
0.1M bicine buffer (Calbiochem), pH8.0, containing 0.1%
BSA. Keratanase {Pseudomonas sp. IFO 13309) and endo-/S-
galactosidase (Escherichia freundii; ICN Biochemicals Inc.)
were applied at O.Oli.u.ml"1 in 50 mM Tris-HCl buffer,
pH7.2, containing 80mM NaCl, 1 mM EDTA, 1 mM iodoaceta-
mide, 1 mM PSMF, and 5^gml~' pepstatin A (Sigma).
Immunohistochemistry
Incubation with primary antibodies (1:50-1:150 in 0.01M
phosphate buffer, pH7.2, containing 0.1 % BSA) was carried
out overnight at 4CC, except for the HNK-1 labelling that was
performed for 2h at room temperature. Antibody-antigen
binding was visualized by indirect immunofluorescence using
Ig-class and species specific secondary antibodies, directly
conjugated to fluorescein, or rhodamine (Zymed Labora-
tories). Double labelling was performed using biotinylated
HNK-1 antibody, visualized by incubation of the sections with
streptavidin-Texas Red complexes (1:200; Amersham).
Labelled sections were mounted in glycerol-Tris-HCl buffer,
pH8.0, containing 2mgml"1 l,4-diazabicyclo(2,2,2,)octane.
In some cases, comparative stainings with anti-PG antibodies
and the HNK-1 antibody were carried out on adjacent
sections to avoid possible steric hindrance effects of IgM
antibodies.
Detection of hyaluronan in tissue sections
Stage 14-23 embryos were fixed in phosphate-buffered 4%
paraformaldehyde, pH7.2, containing 0.5% cetylpyrinidium
chloride and 0.1% polyvinylpyrrolidone (Mr 40000; Sigma)
for 12-18 h at 4 (Derby and Pintar, 1978). Fixed embryos were
rinsed, embedded in gelatin and sectioned as described
above. Tissue sections were incubated with 30-100/.ig
biotinylated hyaluronan probe in 0.1M phosphate-buffered
saline, pH7.2, at 4°C overnight. Sections were then
extensively rinsed in buffer containing 0.01 % Nonidet P-40,
incubated with streptavidin-fluorescein and finally mounted
as described for antibody-labelled sections. Control sections
were predigested with Streptomyces hyaluronidase (Sigma) in
the presence of protease inhibitors (see above), or incubated
with inactivated probe. For the latter purpose, the biotinyl-
ated hyaluronan-binding fragment was preincubated with a
molar excess (100ng ml"1) of hyaluronan oligosaccharides
(16-30) for 1 h at 37°C, dialyzed to remove excess nonbound
oligosaccharides, and then applied to the sections. In some
cases, sections were double-labelled with the hyaluronan
probe and the HNK-1 antibody.
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Confocal laser microscopy
In a number of cases, stained sections were analyzed by
confocal laser microscopy in conjunction with computerized
image analysis. For this purpose, we used a Bio-Rad MRC 500
laser unit attached to an epifluorescent microscope (Nikon,
Labphot), a videoprinter VP 3500 (Seikosha), a 3D6 personal
computer, and Bio-Rad software for image analysis. Relative
staining intensities were analyzed according to an arbitrary
value scale of 0-255 in a series of 74 transversal sections cut
between somite 15 and 22 of stage 17 embryos (29-31 somites)
and stained with mAb 4C3; and a series of 16 horizontal
sections spanning >20 somites of similar age embryos stained
with mAb 7D4. Transverse sections were analyzed in the
medial-lateral plane by single spot measurements across their
dorsal portion, starting and ending in the subepidermal space.
A single spot measurement was also taken within cells of the
neural tube where no immunoreactivity was observed and was
used to correct for the background nonspecific fluorescence.
Analysis in the dorsal-ventral dimension was carried out by
consecutive single spot measurements along an arbitrary
vertical line drawn across the section and passing through the
subepidermal space, the lateral sclerotome, the perichordal
area and finally the periaortic area. Horizontal sections
containing the mid-portion of the neural tube were analyzed
in the rostral-caudal dimension by recurring spot measure-
ments at the borders and center of each somite, and within the
intersomitic clefts, starting from the most recently formed
somite and progressing rostrally. In this case, control values
for correction of the nonspecific background fluorescence
were obtained from the dermamyotome, which consistently
lacked proteoglycan immunoreactivity.
Specificity of the anti-chondroitin/keratan sulfate
mAbs
The characteristics and specificities of the various mAbs are
summarized in Table 1. Immunization of mice with high
buoyant density PGs extracted from bone marrow of 17 days
old chick embryos resulted in nine clones producing mAbs
specific for CS and KS glycosaminoglycans. MAbs 7D4, 6C3,
4D3 and 4C3 all reacted with epitopes expressed on native CS
moieties of cartilage PGs from a variety of sources including
chick epiphysis, bovine arteries and nose, chick bone marrow
and shark cranium (Fig. 1). Although all five mAbs detected
epitopes on CS-PGs, direct and competitive ELISA using five
distinct PG types as model antigens clearly demonstrated that
each antibody detected a different structural element
(Fig. 1A). ELISA also showed that, while the antigenic
profiles of the chick CS-PGs were related, the antigenic
profiles of the other CS-PGs were characteristic for each type.
Combined use of ELISA and chondroitinase ABC digestion
proved that the immunological diversity resided in the CS
chains. Specific epitopes were differentially removed by
various concentrations of enzyme (Fig. IB), consistent with
the idea that each of these antibodies recognized a unique
structural unit. For example, the epitope recognized by mAb
6C3 was ten-fold more sensitive to digestion than those
recognized by 7D4 or 4C3. Recent data indicate that mAbs
7D4, 6C3 and 4C3 primarily recognize CS chains with
prevalent 6-sulfated groups, whereas mAb 4D3 seems to react
primarily with 4-sulfated chondroitins (Sorrell, unpublished).
MAbs 4D1, 3D2, 1B4, 8C2 and 5D4 also recognized
epitopes on CS-PG monomers, biit unlike the five mAbs
described above, these epitopes were not removed by
chondroitinase predigestion of the antigens. In fact, anti-
genicity of PGs for the latter mAbs sometimes increases
following chondroitinase treatment (data not shown). In
Table 1. Specificity and characteristics of the various
mAbs
Antibody
7D4
6C3
4C3
4D3
3B3
1B5
2B6
4D1
3D2
8C2
5D4
33-2
Antigen
CS-PG
CS-PG
CS-PG
CS-PG
CS-PG
CS-PG
CS-PG
(CS)/KS-PG
(CS)/KS-PG
(CS)/KS-PG
(CS)/KS-PG
HS-PG
Reactivity
native CS
native CS
native CS
native CS
Ch6S
ChO
Ch4S/DS
native KS
native KS
native KS
native KS
>300kD CP
Epitope
unknown
unknown
unknown
unknown
GlcUA-6SO4, /V-AcGal
GlcUA, /V-AcGal/Glu
GlcUA-4SO4, JV-AcGal
unknown
unknown
unknown
(N-AcLac)n»fi,SO4
unknown
Note: The epitopes recognized by mAbs 1B5, 3B3 and 2B6 are
generated by chondroitinase ABC/AC II digestion (Couchman et
al. 1984; Caterson et al. 1987), which involves an elimination
reaction introducing a 4,5-delta unsaturation of the GlcUA moiety
of glycosaminoglycan disaccharides. The epitope recognized by
mAb 5D4 comprises a miminum of six sugar units in linear
nonsubstituted sulfated poly-(A'-acetyllactosamine) structures of KS
(Mehmet et al. 1986; Caterson et al. 1987). mAb 2B6 has a dual
reactivity for both Ch4S and DS chains substituted on
proteoglycan core proteins. Its specificity is determined by
chondroitinase ABC or AC II digestion prior to immunostaining.
Following chondroitinase ABC digestion the mAb recognizes both
Ch4S and DS, whereas following chondroitinase AC II digestion it
reacts only with Ch4S. The mAb 3B3 also detects an unidentified
epitope on mature chick cartilage proteoglycans that is not
generated by chondroitinase digestion (Sorrell et al 1990). GlcUA,
glucuronic acid; N-AcGal/Glu, JV-Acetylgalactosamine/
glucosamine; iV-AcLac, yV-Acetyllactosamine; CP, core protein.
contrast, digestion of immobilized embryonic chick cartilage
CS-PG abolished virtually all immunoreactivity for these
mAbs (Fig. 1C). The moderate reduction in immunoreac-
tivity for bovine nasal cartilage CS-PG is likely to be due to
differences in the structure of the KS chains of these two
species-specific PGs.
The overall staining patterns obtained with mAbs 7D4, 6C3
and 4C3 were similar and therefore are described collectively.
However, the extent and intensity of the labelling obtained
with these mAbs decreased in the order 4C3>7D4>6C3,
even though mAb 7D4 reacted 15 times more strongly with
isolated chick proteoglycans than mAb 4C3 (Fig. 1A). Minor
differences in the immunoreactive patterns obtained with
these mAbs were also observed within the sclerotome and in
the perinotochordal area.
Results
Analysis of the distribution of proteoglycans (PGs) and
hyaluronan was carried out in the mid-trunk region at
two developmental stages: during neural crest cell
migration (stages 14-19 at level of somites 12-27;
Fig. 2A) and following gangliogenesis (stages 21-23
between wing and limb buds). Four generalized
patterns of immunoreactivity were distinguishable and
those will be referred to as patterns I-IV (Table 2).
Distribution of chondroitin sulfate proteoglycans (CS-
PGs)
During neural crest cell migration (stages 14-19)
Proteoglycans detected by the mAbs 7D4/6C3/4C3
o/>
CD
3
CD-6C3 ED-4C3 =7D4
10.00-
1.00-
0.10-
0.01 •
1.O0E-3-
1.00E-4 J
CBM CEC SCC BAC BNC
Type of CS-PG
100.00
 T
eo.oo-
40.00- •
20.00 ••
0.00
10,-2 10,-1
B Concentration chondrortinase ABC (U/ml)
K3 • CEE CS—PC
M -CEECS-PC + luratoix—
CD - BNC CS-PG
KB -BNCCS-P0 + karatanaM
1.500
1.200-
0.8OO-
0.300-
0.000
5D+ 3D2 401 BC2
Antibody
were distributed widely along neural crest cell mi-
gratory pathways. The immunostaining patterns pro-
duced by antibodies 7D4/6C3/4C3 (Fig. 2B) were
similar to that of mAb 3B3, which recognizes chondroi-
tin-6-sulfate (Ch6S) moieties following chondroitinase
ABC digestion. Thus, it is possible that the native
epitopes recognized by these antibodies were expressed
on CS chains rich in 6-sulfated groups. This staining
pattern will be refered to as pattern I (Table 2). At
initial stages of neural crest cell migration, pattern I CS-
PGs were detected within the subepidermal basement
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Fig. 1. (A) Competitive ELISA using shark cranial '
cartilage (SCC) proteoglycan as an immobilized antigen
and chick bone marrow (CBM), CEE, bovine articular
cartilage (BAC) and BNC protoglycan monomers as
competing antigens. Values denote means of the amount of
competing proteoglycan yielding 50 % inhibition of the
antibody-antigen binding. The values are expressed as
l/amount of competing proteoglycan and hence a high
value indicates that the proteoglycan was an efficient
competitor of the antibody-antigen binding. MAb 6C3
recognizes an epitope on BNC CS-PG, but 50% inhibition
level was not reached using up to 1000 /.ig ml"1 competing
antigen (*). Because of its low affinity for SCC
proteoglycan, mAb 4D3 could not be tested in this assay.
(B) Concentration-dependent effects of chondroitinase
ABC digestion of immobilized CEE proteoglycan
monomers on the binding of the various mAbs. MAb 2B6
was used as a control for the efficiency of the enzymatic
degradation, since digestion with chondroitinase ABC is
required to generate the epitope recognized by this
antibody (see Table I). The data indicate that CS chains
are degraded at enzyme concentrations higher than
10~4i.u. ml"1. Note that the epitopes recognized by mAbs
6C3, 4C3 and 7D4 are totally removed by the
chondroitinase digestion, but only by enzyme
concentrations considerably higher than those needed to
generate the 2B6 epitope. Each point corresponds to %
values of the maximal adsorbance readings from triplicate
tests. (D) Differential elimination of antibody reactivity
following keratanase digestion of CEE and BNC
proteoglycan monomers (mean values of maximal
adsorbance). The differential reduction in antigenicity seen
for CEE versus BNC CS-PG reflects the inability of
keratanase to digest equally all forms of KS.
Table 2. Generalized patterns of PG distribution
during neural crest development
Pattern Antigens Antibodies
I
II
III
rv
* Following
CS-PG
Ch6S-PG
KS-PG
ChO-PG
KS-PG
CS-PG
Ch4S-PG
DS-PG
KS-PG
HS-PG
chondroitinase AC II
7D4, 6C3, 4C3
3B3
5D4
1B5
4D1, 1B4, 2D3, 3D2
4D3
2B6*
2B6
8C2
33-2
digestion.
membrane, surrounding the neural tube and noto-
chord, and in the ventral portion of the sclerotome
(Fig. 2B). Fibrillar staining was also observed in the
intersomitic clefts and in the perinotochordal region.
However, these PGs were generally absent from
regions through which neural crest cells initially will
migrate (Fig. 3C,D; Bronner-Fraser, 1986b; Newgreen
et al. 1986).
During the course of neural crest cell migration,
pattern I CS-PGs increased considerably in extent and
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intensity within the sclerotome (Fig. 3A,B)- Their
deposition appeared to follow a rostral-to-caudal and
ventral-to-dorsal sequence, first appearing in the
ventral sclerotome concomitant with sclerotome forma-
tion and later appearing in the dorsal sclerotome (4-5
somites rostrad). Twelve to fourteen somites rostral to
the most recently formed somite, pattern I CS-PGs
were observed throughout the sclerotome. The relative
levels of immunoreactivity within the different portions
of the sclerotome were quantitated by confocal laser
microscopy in conjunction with computerized image
analysis. The dorsal sclerotome, containing migrating
neural crest cells (Fig. 2F,G) exhibited a 10-fold lower
staining intensity for 7D4-immunoreactive CS-PGs
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Fig. 2. Histological and immunofluorescent stainings of
transverse and parasagittal sections through the mid-trunk
region of embryos during the course of neural crest cell
migration (stages 16-18). (A) Transverse section through
somite 27 of a stage 16 embryo stained according to the
histological procedure of Lofberg and Ahlfors, (1978),
which allows optimal retention and visualization of the
proteoglycan-rich matrices. Neural crest cells (filled arrows)
emigrating from the dorsal aspect of the neural tube
initially proceed along the neural tube (NT) basement
membrane. Further ventrally, the neural crest cells also
come in contact with the medial surface of the somites
{arrowheads). No cells can be seen migrating in the
subepidermal space, which is particularly rich in CS/KS-
PG. Note also the intercellular occurrence of a
proteoglycan-containing matrix in the ventral portion of the
somites, just prior to segregation of the sclerotome
(Courtesy Drs J. Gunnarson and J. Lofberg). x500.
(B) Distribution of CS-PG recognized by the 7D4mAb
(stage 17; somite 25; pattern I). Note the extremely weak
immunoreactivity in the dorsolateral sclerotome which is
occupied by migrating neural crest cells (open arrowheads)
when compared with the substantially stronger staining in
the ventral portion (Fig. 4, 5). X450. (C) KS-PG detected
by the mAb 5D4 show a faint immunoreactivity within the
lateral sclerotome and the periaortic region (pattern I).
(D) Distribution of KS-PG reactive with the mAb 4D1 at
the level of somite 27 (stage 18; pattern II). Note the
delineation of the subepidermal basement membrane
(arrows) and the extension of the perinotochordal staining
to the supra-aortic region. x350. (E) Distribution of 5D4-
reactive KS-PG within the sclerotome of somites 24-27
(stage 18) viewed in the longitudinal plane (parasagittal
section). A punctate staining can be noted in the caudal (c)
portion of the somites, at the time of neural crest cell
migration through the rostral (r) half. Arrowheads mark
the levels of the intersomitic clefts. x200. (F-G) Double-
labelling with mAb 4C3 (F) and the biotinylated HNK-1
antibody detecting neural crest cells at level with somite 19
of a stage 17 embryo (G). Note the paucity in 4C3
immunolabelling in the area occupied by the migrating
neural crest cells. X55O. N=notochord; NT=neural tube;
DA=dorsal aorta; DM=dermamyotome.
than did the corresponding ventral sclerotome
(Fig. 4B,D). The subepidermal space and neural tube
basement membranes exhibited higher levels of immu-
noreactivity than either the dorsal or ventral sclerotome
(Fig. 4A,C). The differences between dorsal and
ventral immunoreactivty appeared segmental, being
greater at the level of the rostral sclerotome (containing
neural crest cells) than at the caudal sclerotome
(Fig. 4D,E).
At advanced stages of neural crest cell migration,
there was a marked rearrangement of pattern I CS-PG
immunoreactivity. Proteoglycan fibrils were observed
primarily in the caudal sclerotome, but were absent
from the rostral sclerotome in the vicinity of migrating
neural crest cells (Figs 3E,F and 4). At final stages of
neural crest cell migration and the beginning of their
aggregation into peripheral ganglia, pattern I CS-PG
fibrils surrounded the ganglia, but were not found
within them (Fig. 3G,H).
CS-PGs rich in unsulfated chondroitin (ChO) chains
(recognized by mAb 1B5; pattern II) were detected for
the first time during active neural crest cell migration,
where they appeared confined to the notochord and its
adjacent fibrillar matrix. Similarly, CS-PGs recognized
by mAb 4D3 and CS-PGs rich in Ch4S chains (mAb
2B6; pattern III) were observed around the notochord
and ventrolateral subepidermal space, but were absent
from all other regions of the embryo.
Following gangliogenesis (stages 21-23)
After neural crest cells had aggregated to form
peripheral ganglia, pattern I CS-PGs displayed a
metameric arrangement related to the position of the
peripheral ganglia. Between adjacent ganglia, these CS-
PGs were distributed uniformly throughout the lateral
sclerotome, including the perinotochordal region. In
contrast, the ganglia and the ventral roots, containing
axons and neural crest-derived Schwann cells, were
devoid of pattern I CS-PGs (Fig. 5A). CS-PGs carrying
predominantly Ch6S chains (mAb 3B3) persisted in
their colocalization with CS-PGs detected by mAbs
7D4/6C3/4C3 (Fig. 5B), with the exception of the
lateral subepidermal space and the sclerotome adjacent
to the neural tube where the latter PGs were absent.
Ch6S-PGs were distributed metamerically in the ventral
portion of the embryo, within perinotochordal matrix
fibrils extending well into the sclerotome between
adjacent ganglia at sites of prospective vertebral arch
formation (Fig. 5B). No immunoreactivity was ob-
served in the sympathetic ganglia or in the regions of
the presumptive adrenal medulla, splanchnic sympath-
etic plexus and mesenteric ganglia.
Pattern III CS-PGs recognized by mAb 4D3 were
concentrated in the subepidermal space, the sclerotome
surrounding the neural tube (including its basement
membrane) and the perinotochordal region. Between
adjacent ganglia, pattern III CS-PGs formed a dense
fibrillar network, continuous with that surrounding the
notochord and neural tube, and extending ventrally
between the notochord and dorsal aorta in prospective
regions of vertebral arch formation.
The distribution of CS-PGs bearing predominantly
Ch4S (pattern III; mAb 2B6 in conjunction with
chondroitinase AC II digestion) was metameric along
the rostrocaudal extent of the sclerotome (Fig. 5C,D),
with immunoreactivity enriched between adjacent
ganglia in the region of the prospective vertebral
arches. ChO-PGs (pattern II; recognized by mAb 1B5)
were solely observed around the notochord. Both ChO
and Ch4S-bearing CS-PGs were absent from the most
dorsal regions of the embryo and the sclerotome ventral
to the notochord.
Chondroitinase ABC/ AC II digestion of the sections
prior to application of the mAbs 7D4, 4C3, 6C3 and
4D3 entirely abolished staining, demonstrating that the
antibodies reacted exclusively with native CS chains of
tissue proteoglycans. In contrast, if the chondroitinase
ABC/AC II digestion was omitted prior to staining with
antibodies 3B3 (Ch6S), 1B5 (ChO) and 2B6 (Ch4S), no
immunoreactivity was observed, which confirmed the
specificity of the staining with these antibodies for
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Fig. 3. Parasagittal and transverse sections through
embryos at stages of advanced neural crest cell migration
(stages 17-18) showing the representative distribution of
7D4-reactive proteoglycans (pattern I) in relation to
migrating neural crest cells (identified by the HNK-1
antibody). (A,B) Sclerotomal distribution of 7D4-reactive
proteoglycans in the dorsal-ventral dimension. A shows
staining in the most dorsal regions of somites 23-27,
whereas the section in B shows the comparable 7D4
immunolabelling 50-70 ^ m further ventrally. Note also the
rostral to caudal (r-c) sequence of expressional to caudal
(r-c) sequence of expression of 7D4-reactive proteoglycans
within the somites. x200. (C,D) High magnification
photographs illustrating a double-labelling with mAb 7D4
and the biotinylated HNK-1 (binding of the latter antibody
was detected by incubation with streptavidin-Texas Red)
of somite 28 and 29 in the horizontal plane. No 7D4
immunoreactivity can be seen ahead of the neural crest
cells (D), just about to enter the dorsal, rostral portion of
the somite. In contrast, the proteoglycans are heavily
concentrated in the intersomitic clefts and in the interstitial
matrix between neural tube and somites (C), where no
neural crest cells are found. x900. (E,F) Parasagittal
sections through the rostral trunk (somites 11-16). There is
a progressive rearrangement of the 7D4-reactive
proteoglycans from the rostral to the caudal portion of the
somites, which seem to occur coincidently with the invasion
of the rostral portion by the migrating neural crest cells.
x200 (G,H) Parallel staining of two adjacent horizontal
sections with mAbs 7D4 (G) and HNK-1 (H). Note how
7D4-reactive proteoglycans are secluded from the
sclerotomal area of neural crest cell coalescence into
peripheral ganglia. x450.
epitopes generated by such enzymatic treatment
(Couchman et al. 1984).
Distribution of dermatan sulfate proteoglycans (DS-
PGs)
The distribution of DS-bearing proteoglycans was
defined by comparing the staining patterns observed for
the mAb 2B6 following either chondroitinase ABC or
chondroitinase AC II pre-digestion. DS-PGs were not
immunohistochemically detectable at stages of initial
neural crest cell migration. During advanced stages of
neural crest cell migration, immunoreactivity for DS-
PGs was confined to the notochordal basement mem-
brane and its associated fibrillar matrix (pattern III). At
postganglionic stages, DS-PG immunoreactivity
became more heavily concentrated in the perinotochor-
dal region, and also appeared in the ventral sclerotome,
perioaortic region, and subepidermal space. DS-PGs
appeared in a metameric pattern similar to that of
Ch4S-PGs in the ventral sclerotome at sites of
presumptive vertebral arch formation.
Distribution of keratan sulfate proteoglycans (KS-
PGs)
During neural crest cell migration (stages 14-19)
At initial stages of migration, immunoreactivity with
the 5D4 antibody (pattern I KS-PGs; Table 2) was
similar to that of Ch6S, but was considerably less
widespread and weaker in interstitial matrices. In
contrast, immunolabelling with the 4D1, 1B4, 2D3,
3D2 (pattern II KS-PGs; Fig. 2C) and 8C2 antibodies
(pattern IV KS-PGs) was observed primarily around
the notochord, with some discontinuous staining in the
subepidermal space for pattern IV KS-PGs.
With progressive neural crest cell migration, the
intensity and distribution of pattern I, II, and IV KS-
PGs increased in a region-specific manner. A punctate
staining for pattern I KS-PGs appeared at advanced
phases of neural crest cell migration and accompanied
the distribution of pattern I CS-PGs. Distribution of
pattern I KS-PGs within the sclerotome initially was
uniform, but became progressively excluded from the
rostral portion during the course of neural crest cell
migration (Fig. 2E).
Pattern IV KS-PGs extended throughout the sclero-
tome, the intersomitic space, the perinotochordal
matrix and were sparsely distributed around the neural
tube surface (Fig. 5E,F). Deposition of pattern IV KS-
PGs preceded and was more abundant than that of
pattern I KS-PGs. In contrast to pattern I CS-PGs
(Fig. 3A,B) which increased in distribution in a ventral-
to-dorsal sequence, Pattern IV KS-PGs were aug-
mented in a dorsal-to-ventral sequence (Fig. 5E,F)
during the course of neural crest development.
Pattern II KS-PGs were heavily concentrated in the
perinotochordal and supra-aortic region, and the
subectodermal basement membrane (Fig. 2D). In
contrast, immunoreactivity for pattern IV KS-PGs was
persistently confined to the perinotochordal area.
Following gangliogenesis (stages 21-23)
Immunoreactivity for pattern I KS-PGs increased and
largely coincided with that of pattern I CS-PGs in the
dorsal regions of the embryo and in the lateral
sclerotome (Fig. 5G) at interganglionic levels. How-
ever, some differences were noted; for example, these
KS-PGs filled the entire subepidermal space and were
sparsely distributed in the perinotochordal region and
ventral sclerotome at axial levels containing the
peripheral ganglia (Fig. 5G). No staining was observed
in the sclerotome surrounding the neural tube at any
axial level, though immunoreactivity was observed
within the neurogenic region and roofplate of the
neural tube.
Pattern IV KS-PG immunoreactivity increased at
postmigratory stages, and was apparent throughout the
lateral sclerotome at all axial levels. These KS-PGs
were widespread within the ganglia and ventral roots,
and were largely absent from the medial sclerotome and
around the neural tube (Fig. 5H). To determine
whether pattern IV KS-PG immunoreactivity was
present on neural crest-derived cells, sections were
double-labelled with mAb 8C2 and the HNK-1 anti-
body. Although 8C2 staining was present within the
ganglia and ventral roots, it appeared distinct from that
produced by the FINK-1 antibody. In the ventrolateral
sclerotome, pattern IV KS- PGs were concentrated in
the area occupied by neural crest cells forming the
sympathetic ganglia. Although outlining the dorsal
aorta, pattern IV immunoreactivity largely was absent
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from the peri-aortic region through which adrenome-
dullary cells and the splanchnic sympathetic plexus
precursors move. Pattern IV KS-PGs were pronounced
at the sclerotomal-myotomal interface and the noto-
chordal basement membrane.
Pattern II KS-PGs remained concentrated in the
Proteoglycans in avian neural crest development 593
Fig. 4. Relative measurements of regional
immunofluorescent intensities by confocal laser microscopy
and computerized image analysis. The intensity levels were
estimated by the image analysis program according to an
arbitrary scale of 0-255. (A,B) DiagTamatic representation
of the measured areas (1-7) in the mediolateral plane (A)
and dorsoventral plane (B). (C) Spot measurement of mAb
4C3 immunofluorescent intensity across the dorsal portion
(medial-lateral plane; see A) of serial transverse sections
through somites 17-22 of three different embryos (a total
of 74 sections). Bars represent mean values±s.D. Rostral,
Center and Caudal denote the rostrocaudal level at which
the section was cut through the somite. At level rostral, the
most advanced neural crest cells were seen level with the
perinotochordal area. At level center, the most advanced
cells had reached a level corresponding to the middle of
the neural tube. At level caudal, only a few neural crest
cells could be seen on the dorsolateral aspect of the neural
tube. (D) Similar measurements as in C, but in
dorsoventral plane (see B). (E) Immunofluorescent
intensity measurements in the horizontal plane following
staining with mAb 7D4. The analysis includes 16 sections
from two embryos, each section comprising 20 or more
somites. Measurements were carried out within the caudal,
middle and rostral portion of each somite and in the
intersomitic clefts, starting from the intersomitic cleft of
the most recently formed somite (somite 1) and progressing
rostrally (end=somite 20). The upper panel shows
graphically the total fluorescence measurements, starting
from the intersomitic cleft between the last and
penultimate somite and progressing rostrally. In the lower
panel, curves depict the rostrocaudal variations in
immunofluorescent intensity in the intersomitic cleft,
caudal, medial and rostral portions of the last 20 somites.
perinotochordal space and along the ventral neural tube
following ganglion formation. Pattern II KS-PGs also
prominently stained the mesonephric tubules and fibrils
within the adjacent periaortic sclerotome.
Keratanase (Pseudomonas sp.) and endo-/J-galactosi-
dase (Escherichia freundii) digestion of sections
reduced immunoreactivity for mAbs 5D4, 4D1, 1B4,
2D3, 8C2 and 3D2, indicating that the epitopes
recognized by these antibodies were on native KS
chains. At stages of neural crest cell migration,
keratanase removed all immunoreactivity for mAbs
5D4, 1B4 and 4D1, whereas some immunoreactivity
remained around the notochord after digestion with
endo-/J-galactosidase. At postganglionic stages, kera-
tanase and endo-/J-galactosidase treatment completely
abolished immunoreactivity for mAb 4D1, but not 5D4.
Similarly, some mAb 8C2 immunoreactivity persisted
subepidermally and around the dorsal neural tube after
endo-/J-galactosidase, whereas keratanase digestion
eliminated all staining. The differential susceptibility to
enzymatic degradation indicates that the populations of
KS-PGs detected during neural crest cell migration
were heterogeneous, carrying unbranched KS chains
with both monosulfated and non-sulfated A'-acetyllac-
tosamine repeating units (Ito et al. 1986). Interestingly,
the differential susceptibility to enzymatic digestion
suggested that pattern IV KS-PGs associated with
migrating and post-migratory neural crest cells (mAb
8C2) were abundant in undersulfated KS chains,
whereas those largely absent from the migratory
pathways (mAbs 5D4, 4D1 and 3D2) were more
heavily sulfated.
Distribution of a heparan sulfate proteoglycan (HS-
PG)
At initial neural crest cell migration, immunoreactivity
for the mAb 33-2 (pattern IV HS-PG; Table 2) was
evident in the all basement membranes surrounding the
neural tube and notochord, along the basal side of the
epidermis, and on the dorsolateral dermamyotome. In
contrast to CS/DS/KS-PGs, no HS-PG staining could
be observed in the interstitial matrix. During the course
of neural crest cell migration, pattern IV HS-PG
immunoreactivity persisted along basement membranes
and also became evident within the somitic sclerotome
(Fig. 6A). In this region, it occurred in a uniformly
arranged fibrillar pattern that accompanied the ex-
pression of CS/KS-PGs (Fig. 6B). With continued
neural crest cell migration through the rostral portion of
the somites and subsequent coalescence of the pregang-
lionic cells, HS-PG-containing matrix fibrils became
restricted to the ganglia and little or no immunoreac-
tivity could be detected in the surrounding sclerotome.
Following gangliogenesis, HS-PG immunoreactivity
was primarily localized in basement membranes, but
also occurred in a punctate pattern within the newly
formed dorsal root ganglia and surrounding Schwann
cells of the ventral roots/rami communicans (Fig. 6C).
No staining could be seen within the sympathetic
ganglia, the sclerotome surrounding the dorsal root
ganglia and notochord, or the periaortic region. The
pattern of HS-PG immunoreactivity coincided with that
of its potential matrix ligands collagen type IV (Perris et
al. 1990a) and laminin (Krotoski et al. 1986). The one
exception is that collagen type IV and laminin remain
detectable within the sclerotome after gangliogenesis,
whereas HS-PG does not remain detectable (Fig. 6C).
Distribution of hyaluronan
The distribution of hyaluronan was determined by using
a specific probe (Knudsen and Toole, 1984; Rippellino
et al. 1985) consisting of a biotinylated fragment from
the hyaluronan-binding region of the bovine nasal
cartilage proteoglycan. At stages of early neural crest
cell migration, hyaluronan was found widely distributed
along neural crest migratory pathways. This glycos-
aminoglycan did not appear to be associated with
basement membranes, but rather occurred in fibrillar
structures apposed to basement membranes. A con-
siderable amount of hyaluronan was seen within the
epithelial somites and around the notochord. High
levels of staining were detected above the dorsal neural
tube in the vicinity of early migrating neural crest cells,
particularly along the subepidermal region through
which neural crest cells migrate to form melanocytes
(Fig. 7A).
During the period of early and advanced neural crest
cell migration, abundant amounts of hyaluronan were
detected in the ventral regions of the sclerotome. The
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Fig. 5. Distribution of CS-PG and KS-PG at stages of
advanced neural crest cell migration (stages 17-18; E,F)
and following gangliogenesis (stage 23; A-D,G,H).
(A) Distribution of CS-PG reactive with mAb 7D4 at
stages proceeding gangliogenesis at an axial level
immediately below the wing bud region (pattern I). Both
dorsal root ganglia (DRG) and ventral roots (VR) were
enmeshed in a CS-PG-rich matrix, but no immunoreactivity
could be seen within these nervous structures.
Immunolabelling was also weak or entirely absent on the
dorsolateral aspect of the neural tube. (B) Distribution of
Ch6S-PG (mAb 3B3; pattern I) at an axial level caudal of
the wing bud region and separating the ganglia (stage 23).
Note the lateral restriction of the sclerotomal labelling and
the lack of significant immunoreactivity in the lateral
subepidermal space. (C,D) Ch4S-PG (mAb 2B6 plus
chondroitinase AC II digestion) at axial levels of the
peripheral ganglia (C) and intermediary axial levels
corresponding to prechondrogenic sites of vertebra
formation (D; stage 23). Both sections run across the wing
bud region. X200. (E) Distribution of KS-PG recognized
by mAb 8C2 (pattern IV) during advanced (stages 17-18)
in an oblique longitudinal section through the dorsal
portion of the neural tube (NT) of a stage 17 embryo
(somites 22-25) showing the intrasomitic distribution of
8C2-reactive KS-PG. These KS-PG were concentrated
along the rostral medial surface of the somites {arrows)
and were initially localized in the rostral sclerotome
{arrowheads). X400. (F) Longitudinal section of the same
truncal region as in E, but cut at the level of the
notochord, shows the distribution of 8C2-reactive KS-PG
in the ventral portion of the sclerotome. x850. Note the
absence of 8C2 immunoreactivity within sclerotome.
(G) Distribution of KS-PG recognized by mAb 5D4 at an
axial level just above the limb buds (pattern I).
SG=sympathetic ganglion. x200. (H) Distribution of KS-
PG recognized by the 8C2 antibody in a transverse section
of a stage 23 embryo (7 somites rostral to the limb bud
region) showing distribution of this KS-PG following
gangliogenesis. In contrast to all other CS/KS-PG, KS-PG
recognized by this rhAb were seen within the ganglia.
x950.
hyaluronan density, as evaluated by staining intensity,
was greatest adjacent to the notochord and decreased
progressively outward into the distal sclerotome. No
hyaluronan was detected in the dermamyotome or
neural tube (Fig. 7B). Along the rostrocaudal extent of
the sclerotome, hyaluronan-rich fibrils were uniformly
distributed and extended between, but not across the
intersomitic clefts. As neural crest cell migration ceases
and gangliogenesis commences, the levels of hyaluro-
nan appeared reduced in the immediate vicinity of
neural crest cells. Expression of hyaluronan was weaker
in the peripheral ganglia when compared with the
strong and uniform interstitial expression observed
throughout the sclerotome and subepidermal space
(Fig. 7C).
Streptomyces hyaluronidase digestion of the sections
prior to application of the probe completely eliminated
reactivity. Similarly, inactivation of the probe by
oligosaccharide-saturation of its binding site signifi-
cantly depleted its ability to detect hyaluronan in tissue
sections.
Fig. 6. Immunolocalization of HS-PG detected by the
mAb 33-2 (pattern IV) at stages of advanced neural crest
cell migration and proceeding gangliogenesis. Distribution
of HS-PG in the transverse (A) and parasagittal (B) planes
at stages of advanced neural crest cell migration (stage 17).
Apart from basement membranes, both matrix molecules
also occurred in uniform fibrillar patterns within the
sclerotome (SC). (C) Transverse section at stage 22-23
following gangliogenesis. The section is oblique passing
through a dorsal root ganglion on one side (left) and at an
intersegmental level on the other side. HS-PG was
observed within the peripheral ganglia and ventral roots.
R=rostral; C=caudal; NT=neural tube; N=notochord;
DA=descending/dorsal aorta; HG=hindgut. A, x2(X);
B, x500; C, X200.
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Discussion
In the present study, the distribution of proteoglycans
was related spatially and temporally with the develop-
ment of avian neural crest cells, by using a panel of
Fig. 7. Sections reacted with the biotinylated hyaluronan
probe, followed by incubation with a
streptavidin-fluorescein conjugate, and illustrating the
widespread distribution of hyaluronan (HA) in the
transverse plane during the course of neural crest cell
migration (somite 17; stage 17; A) and in the transverse
(B) and parasagittal (C) planes following gangliogenesis
(wing bud region, stages 22-23). Note the high levels of
(HA) on the dorsolateral aspect of neural tube containing
migrating neural crest cells {arrowheads), and. the
comparatively low expression of (HA) in the sclerotomal
region corresponding to the presumptive sites of dorsal
root ganglion formation (arrows). However, HA was
abundantly distributed in the perinotochordal area, ventral
sclerotome and periaortic region, which correspond to the
prospective sites of sympathetic ganglion formation and the
putative migratory pathway of neuroendocrine precursor
cells. (B) Distribution of HA following gangliogenesis
(stage 23) at an axial level intersegmental to that of the
peripheral ganglia. (C) Distribution of HA viewed in the
longitudinal plane (horizontal section) through the
sclerotome (stage 20). Note the considerably lower levels
of HA in the dorsal root ganglia (DRG) in comparison
with the surrounding sclerotome, and the absence of HA in
the neural tube basement membrane. NT=neural tube;
N=notochord; SC=sclerotome; DA=dorsal/descending
aorta; DM=dermamyotome. A-B, x200; C, x600.
monoclonal antibodies produced against proteoglycan
moieties. Four patterns of immunoreactivity were
distinguished by this comparative study: (1) CS/KS-
PGs rich in Ch6S chains and recognized by mAb 7D4,
6C3, 4C3 and 5D4 were abundantly distributed
throughout the embryo during all phases of neural crest
development, but were largely absent from the areas
occupied by migrating neural crest cells and their
derivatives (pattern I); (2) CS/KS-PGs bearing primar-
ily unsulfated chains and recognized by mAbs 4D1,
1B4, 3D2 and 2D3 consistently were restricted to the
perinotochordal region (pattern II); (3) CS/DS-PGs
rich in Ch4S chains and recognized by mAbs 4D3 and
2B6 were present in the ventral subepidermal space and
notochordal region during neural crest cell migration
and appeared in areas of presumptive chondrogenesis
after the time of gangliogenesis (pattern III); and (4)
KS-PGs and an HS-PG, recognized by 8C2 and 33-2
antibodies, respectively, that were widely distributed
along the migratory pathways during the course of
neural crest cell movement, and which later occurred
within the structures formed by the neural crest.
Hyaluronan was often colocalized with the first set of
proteoglycans, but was also prevalent around migrating
neural crest cells which seemed to have reduced levels
of hyaluronan at postmigratory stages.
The production of a number of monoclonal anti-
bodies with the unique ability to recognize specific
moieties of PGs enabled the identification of various
classes of PGs in situ. When tested in ELISA, all mAbs
were found to react with chick cartilage CS/KS-PGs, as
well as with a variety of other species-specific proteogly-
cans. Further characterization of the antibodies by
competitive ELISA and differential enzymatic diges-
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tion demonstrated that mAbs 7D4, 6C3, 4C3 and 4D3
specifically recognized discrete epitopes on native CS
chains, whereas mAbs 4D1, 1B4, 2D3, 8C2 and 3D2
reacted with KS chains of proteoglycans. The specificity
of the epitopes recognized by both anti-CS and anti-KS
antibodies was shown by their distinguishable affinities
for different purified proteoglycans and by their
divergent immunochemical properties (Sorrell et al.
1988, 1990; Sorrell and Caterson, 1990). The identity of
the epitopes recognized by the anti-KS antibodies was
further demonstrated by their differential affinity for
keratanase-digested proteoglycan antigens.
Staining of chick embryos during the course of neural
crest development with mAbs 7D4, 6C3 and 4C3
yielded strikingly similar patterns. However, this does
not necessarily imply that the mAbs recognized the
same proteoglycan molecule. The possibility remains
that the mAbs may identify distinct proteoglycan
classes that colocalize and share common glycosamino-
glycan epitopes. Alternatively, the glycosaminoglycan
epitopes may reside on different proteoglycan core
proteins. Changes in the distribution patterns observed
at various phases of development may have reflected
developmentally related substitutions of the glycos-
aminoglycan determinants of the same proteoglycans
molecules.
At stages of initial neural crest cell movement, the
interstitial matrix around the dorsolateral neural tube
and sclerotome contained abundant amounts of hyalur-
onan, but little or no proteoglycan. Other areas that are
rich in a variety of CS/KS-PGs (including the subepi-
dermal space, the area around the ventral neural tube,
the notochord and the intersomitic clefts) either
entirely lack neural crest cells at early stages of
migration (Bronner-Fraser, 19866; Newgreen et al.
1986) or, in the case of the intersomitic clefts, contain
only a minority of neural crest cells (Lallier and
Bronner-Fraser, 1988). With progressive neural crest
cell migration within the somites and concomittant
dispersion of the sclerotomal cells, there was a
concomitant increase in the amount of CS/KS-PGs
deposited in the interstitial matrix of the sclerotome.
This accumulation of PGs appeared following the
entrance of neural crest cells, but extended rapidly
throughout the sclerotome; thus neural crest cells
moved toward embryonic areas dense in proteoglycans.
With progressive migration and the condensation of
neural crest cells into peripheral ganglia, the rostral
portion of the sclerotome became virtually devoid of
CS/KS-PGs (recognized by the mAbs 5D4, 4D1 and
3D2) immunoreactivity. However, some hyaluronan,
HS-PG, and KS-PGs, identified by the 8C2mAb, were
observed. It is unclear why HS-PG and some forms of
KS-PGs are expressed within the peripheral ganglia and
ventral roots, but these molecules may have been
retained on the cell surface or synthesized by the neural
crest-derived neurons and/or glia. The absence of
certain CS/KS-PGs from areas occupied by migrating
and post-migratory neural crest cells is intriguing in the
light of previous reports suggesting that these molecules
may inhibit neural crest cell migration. It has been
shown that the CS/KS-PGs from bovine nasal cartilage
impede neural crest cell locomotion on a number of
motility-promoting matrix molecules in vitro (Perris
and Johansson, 1987; Perris, 1990; Perris et al. 19906).
The Swarm rat chondrosarcoma proteoglycan and a
chick brain proteoglycan also have been found to be
nonpermissive for neural crest cell attachment and
migration (Newgreen, 1982; Tan et al. 1987). These
findings in conjunction with previous in vivo obser-
vations in both avians and amphibians (Newgreen et al.
1982, 1986; Tucker, 1986; Tan et al. 1987; Perris et al.
19896; Perris, 1990) suggest that the local assembly of
CS/KS-PGs in the matrix may participate in the
restriction and cessation of neural crest cell movement.
The proteoglycans found to be inhibitory for neural
crest cell migration in vitro, such as the bovine nasal
cartilage CS/KS-PGs and the chondrosarcoma CS-
PGs, have a high content of low sulfated chondroitin/
high sulfated keratan and prevalence of Ch4S chains
(Heinegard and Paulsson, 1984). Interestingly, we
observed that proteoglycans with such characteristics
were invariably secluded from the primary migratory
pathways of the neural crest. In contrast, there is
evidence that PGs recognized by mAbs 6C3, 7D4, and
4C3 are oversulfated (Sorrell, unpublished).
Several explanations could account for the low levels
of CS/KS-PG immunoreactivity around migrating
neural crest cells and their derivatives. Migrating neural
crest cells could suppress the secretion and matrix
assembly of CS/KS-PGs by the surrounding tissues.
Alternatively, neural crest cells and/or adjacent sclero-
tomal cells could specifically degrade the CS/KS-PGs.
A third possibility is that a high rate of hyaluronan
shedding from migrating neural crest cells could
exclude proteoglycans from the cell surface. High levels
of hyaluronan were observed in association with
migrating neural crest cells within the dorsolateral
sclerotome. It has been suggested that high levels of
hyaluronan may be required for the emigration of
neural crest cells from neural tubes cultured in the
presence of serum CS-PGs (Luckenbill-Edds and
Carrington, 1988). Moreover, enhanced hyaluronan
synthesis elevates the motility of fibroblasts within
collagen gels that contain serum CS-PGs (Chen et al.
1989). We have recently demonstrated that inhibition of
neural crest cell migration by CS/KS-PGs requires the
close apposition of the proteoglycans with the cell
surface, via binding to cell surface hyaluronan (Perris
and Johansson, 1990). Thus, in areas sparsely popu-
lated with proteoglycans, continuous shedding of
hyaluronan from migrating cells may displace proteo-
glycans from the cell surface, providing a proteoglycan-
free microenvironment. In contrast, in regions rich in
proteoglycans, such displacement of PGs could be
reduced by overwhelming levels of hyaluronan, produc-
ing a proteoglycan-rich environment around the cells.
Consistent with previous observations (Derby, 1978;
Pintar, 1978), we noted that the level of hyaluronan
around post-migratory neural crest cells was consider-
ably lower than that around migrating cells. Thus, the
balance between extracellular proteoglycans and intra-
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cellular synthesis of hyaluronan may participate in
and/or be a consequence of the regulation of neural
crest cell migration.
Our findings indicate that a distinct segregation of
proteoglycan populations occurs during development,
in a fashion that relates to both neural crest cell
migration and formation of the axial vertebrae. In the
perinotochordal region, CS/KS-PGs recognized by the
mAbs 4D3, 4D1, 2B6, 3D2 and rich in Ch4S/ChO
chains accumulated around the notochord and its
surrounding fibrillar network, whereas Ch6S-bearing
proteoglycans, CS/KS-PGs reactive with mAbs 7D4/
6C3/4C3, 8C2 and 5D4 and HS-PG were considerably
less abundant or entirely absent from this region.
•However, these latter proteoglycans together with DS-
PGs were enriched in the dorsal and lateral sclerotome,
and in the subectodermal space. The differential
occurrence of characteristic cartilage proteoglycans
detected by the former antibodies produced a meta-
meric pattern that inversely correlated with ganglion
formation and 'prematurely' defined the presumptive
chondrogenic sites of vertebral arch formation. In fact,
these proteoglycans were restricted to the perinoto-
chordal space and ventral sclerotome at axial levels
containing the ganglia, but extended throughout the
lateral and dorsal sclerotome at interganglionic levels.
The fibrillar network of cartilage-type proteoglycans
emanating from the notochord extended to the region
of the ventral motor roots (Bronner-Fraser, 1986b).
In conclusion, our comprehensive analysis of the
spatial and temporal distribution of proteoglycans
indicates that these molecules have differential distri-
bution patterns at times of neural crest migration and
that these patterns are modified during development. In
several in vivo (Newgreen et al. 1982, 1986; Tucker,
1986; Tan et al. 1987; Perris, 1990; Perris et al. 19906)
and in vitro (Newgreen, 1982; Newgreen et al. 1982; Tan
et al. 1987; Perris, 1990; Perris and Johansson, 1987,
1990) systems, localized accumulation of proteoglycans
correlates with the restriction of neural crest cell
migration. Consistent with this, the dorsal subepider-
mal space is extremely rich in proteoglycans at stages
when neural crest cells begin their ventral migration,
although neural crest cells do not migrate into the
subepidermal region until later stages (Serbedzija et al.
1989). The area around the ventrolateral neural tube,
the intersomitic clefts and the perinotochordal region
are also particularly densely populated with proteogly-
cans and these regions also lack migrating neural crest
cells. During neural crest cell migration, the caudal
sclerotome retains a proteoglycan-rich network,
whereas the rostral sclerotome containing neural crest
cells loses its proteoglycan-immunoreactivity. Finally,
proteoglycans of prevalent cartilage-type accumulate
metamerically in subnotochordal and periaortic re-
gions, which are inversely correlated with sites of
sympathetic ganglion and aortic plexus formation.
Future efforts will be directed toward isolation of
region- and age-specific classes of proteoglycans and
disturbance of their deposition and/or assembly in situ
in order to clarify their roles in neural crest cell
migration, gangliogenesis and formation of the axial
vertebrae. The use of our immunological probes will
facilitate these studies, since these identify specific
populations of PGs that have been extracted from
tissue.
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excellent technical assistance. This study was supported by
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Association. MB-F is a Sloan Research Fellow.
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